A potential positive role for HCMV in response to ICB was first noted in a single-cell transcriptomic study of peripheral immune responses in 40 patients with MM who had undergone treatment with combination anti-LAG-3/anti-PD-1 immunotherapy [120]. Here, LAG3 is linked to Miyoshi myopathy.